The World Health Organization Prequalification Team - Medicines (PQT Medicines) will be attending the Shanghai SNIEC CPhi on 18-20 June 2019, in Shanghai, China.
For most international procurement agencies, WHO prequalification or stringent regulatory approval is a prerequisite when applying for medicine tender contracts. WHO-prequalified finished pharmaceutical products (FPPs) and active pharmaceutical ingredients (APIs) are publicly listed and recognized as meeting international quality and good manufacturing practice requirements. Increasingly, the prequalification status of an FPP and API is accepted by national regulatory authorities in Low and Middle Income Countries (LMICs) and leads to faster registration.
- The focus of PQT Medicines is medicines and APIs needed for treating high-burden diseases and include diarrhoeal disease, hepatitis B and C, HIV/AIDS, influenza, malaria, neglected tropical diseases, reproductive health and tuberculosis. A complete list of APIs and FPPs invited for prequalification can be viewed at: https://extranet.who.int/prequal/content/products-eligible-prequalification
PQT Medicines will be joining other regulators to present at CPhI International Agencies Updates and Q&A Session, hosted by China Chamber of Commerce for Import & Export of Medicines and Health Products (CCCMHPIE) on afternoon of the 19 June 2019.
One on One meetings with Manufacturers
PQT Medicines will also be offering the opportunity for manufacturers to meet with PQT Medicines assessment and inspection staff at the nearby Kerry Pudong Hotel on the 18 June (09:00-17:00), 19 June (09:00-14:00) and 20 June (09:00- 12:00) to answer questions regarding FPP and API prequalification procedures.
Companies who would like to arrange a face-to-face meeting for either of those days should request a meeting form via email to:
For further information please contact Dr Antony Fake at: email@example.com